Spaictra joins iXcampus: a major breakthrough for quantum optics in healthcare

Spaictra, supported by the LuminEdge incubation program launched by IOGS, iXcampus, and HEC Paris, has set up operations in the heart of the Saint-Germain-en-Laye technology campus. This deeptech startup, specialized in quantum optics applied to medical analysis, embodies both the scientific ambition and entrepreneurial drive that we actively support every day.

From left to right: Maxime Jacquet (CSO), Sophia Mejjati (Co-founder and CEO), Antoine Tessier (Co-founder and CTO) of Spaictra.

A game-changing technology for healthcare

Founded by experts from both academia and industry, Spaictra is revolutionizing blood analysis. Its technology enables the full quantification of a biological sample’s components using only light without any chemical reagents.

By eliminating conventional protocols that are lengthy and costly, Spaictra makes molecular analysis faster, more affordable, and more accessible, while also reducing the environmental impact of diagnostic testing. This breakthrough paves the way for new practices in medical biology, particularly in emergency settings and personalized medicine.

iXcampus: an innovation ecosystem in the west of Paris

Spaictra’s move to iXcampus perfectly reflects our ambition: to establish a center of scientific and technological excellence focused on photonics, quantum technologies, and nanotechnologies.

By joining this environment, Spaictra gains access to a unique ecosystem—both technological and entrepreneurial—designed to foster advanced experimentation, high-level scientific collaboration, and the industrialization of breakthrough technologies.

A dynamic powered by visionary minds

We warmly thank Sophia Mejjati and Antoine Tessier, the founders of Spaictra, for their trust. Their journey, scientific rigor, and entrepreneurial spirit embody the new generation of researcher-entrepreneurs we are proud to support.

Learn more